Protein aggregation is implicated in numerous diseases, especially neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease. In Alzheimer’s Disease, for example, the aggregation of beta-amyloid peptides leads to the formation of plaques that disrupt neuronal function. Similarly, in Parkinson’s Disease, alpha-synuclein aggregation forms Lewy bodies that are toxic to neurons.
